Join Growin Stock Community!

卜蜂1215.TW Overview

TW StockFoods
(No presentation for 1215)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

卜蜂(1215)Overall Performance

卜蜂(1215)AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

卜蜂(1215) PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

卜蜂(1215)Key Information

卜蜂(1215)Profile

Charoen Pokphand Enterprise (Taiwan) Co., Ltd. engages in the agriculture, animal husbandry, and meat businesses in Taiwan and Asia. The company operates through Feed Business Group, Meat Processing Business, Food Processing Business, Egg Chicken Business, and Other segments. It produces and sells feed for chickens, pigs, ducks, cattle, and other animals; develops and sells chicken processed products; and imports and supplies vaccines poultry vaccines, pig vaccines, antimicrobial, feed additives, feed quality raw materials, natural health agents, cleaning and disinfectant products, and diluent for artificial insemination. In addition, it engages in the provision of husbandry management services for chickens to produce eggs and meat; chicken and pig breeding; and electric slaughtering of poultry. The company was formerly known as Taiwan Pokphand Feed Co., Ltd. and changed its name to Charoen Pokphand Enterprise (Taiwan) Co., Ltd. in 1988. The company was founded in 1921 and is based in Taipei City, Taiwan.

卜蜂(1215)FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
10.21
PE Ratio (TTM)
15.27
Forward PE
17.26
PS Ratio (TTM)
1.63
PB Ratio
3.81
Price-to-FCF
33.55
METRIC
VALUE
vs. INDUSTRY
Gross Margin
20.98%
Net Margin
10.69%
Revenue Growth (YoY)
1.21%
Profit Growth (YoY)
30.41%
3-Year Revenue Growth
-0.55%
3-Year Profit Growth
18.91%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
10.21
PE Ratio (TTM)
15.27
Forward PE
17.26
PS Ratio (TTM)
1.63
PB Ratio
3.81
Price-to-FCF
33.55
Gross Margin
20.98%
Net Margin
10.69%
Revenue Growth (YoY)
1.21%
Profit Growth (YoY)
30.41%
3-Year Revenue Growth
-0.55%
3-Year Profit Growth
18.91%
default symbol

1215

卜蜂

156.00D

0.32%

(0.00)

  • When is 1215's latest earnings report released?

    The most recent financial report for 卜蜂 (1215) covers the period of 2025Q3 and was published on 2025/09/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating 1215's short-term business performance and financial health. For the latest updates on 1215's earnings releases, visit this page regularly.

  • Where does 1215 fall in the P/E River chart?

    According to historical valuation range analysis, 卜蜂 (1215)'s current price-to-earnings (P/E) ratio is 11.05, placing it in the Watch zone on the P/E River chart. This level indicates that the market's expectations for future earnings are already reflected in the share price, with the valuation currently leaning optimistic. Investors are advised to further examine the company's fundamentals and its position in the industry cycle to validate whether the valuation is justified.

  • What is the operating profit of 1215?

    According to the latest financial report, 卜蜂 (1215) reported an Operating Profit of 1.01B with an Operating Margin of 14.21% this period, representing a growth of 133.64% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is 1215's revenue growth?

    In the latest financial report, 卜蜂 (1215) announced revenue of 7.09B, with a Year-Over-Year growth rate of 1.14%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much cash does 1215 have?

    At the end of the period, 卜蜂 (1215) held Total Cash and Cash Equivalents of 508.63M, accounting for 0.02 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does 1215 go with three margins increasing?

    In the latest report, 卜蜂 (1215) achieved the “three margins increasing” benchmark, with a gross margin of 22.22%%, operating margin of 14.21%%, and net margin of 12.48%%. This demonstrates improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess 1215's profit trajectory and future growth potential.

  • Is 1215's EPS continuing to grow?

    According to the past four quarterly reports, 卜蜂 (1215)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at 2.99. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What is the FCF of 1215?

    卜蜂 (1215)'s Free Cash Flow (FCF) for the period is -705.04M, calculated as Operating Cash Flow minus Capital Expenditures, representing a fall of 115.01% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.